Resmed (RMD) Equity Income (2020 - 2022)

Resmed (RMD) posted Equity Income of -$1.7 million for Q1 2022, up 60.6% on a QoQ basis from -$4.4 million in Q4 2021, and down 137.18% year-over-year from $4.7 million in Q1 2021.

Resmed (RMD) Equity Income (2020 - 2022) Analysis & Trends

Resmed's Equity Income history runs 3 years deep, the most recent figure standing at -$1.7 million for Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 2.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 -1.74 Mn
Dec 31, 2021 -4.40 Mn
Sep 30, 2021 5.61 Mn
Mar 31, 2021 4.67 Mn
Dec 31, 2020 -3.70 Mn
Sep 30, 2020 8.50 Mn